101 related articles for article (PubMed ID: 3559652)
1. Cisplatin therapy for disseminated mixed mesodermal sarcoma of the uterus.
Gershenson DM; Kavanagh JJ; Copeland LJ; Edwards CL; Stringer CA; Wharton JT
J Clin Oncol; 1987 Apr; 5(4):618-21. PubMed ID: 3559652
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin and adriamycin combination chemotherapy for uterine stromal sarcomas and mixed mesodermal tumors.
Peters WA; Rivkin SE; Smith MR; Tesh DE
Gynecol Oncol; 1989 Sep; 34(3):323-7. PubMed ID: 2767523
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.
Thigpen JT; Blessing JA; Orr JW; DiSaia PJ
Cancer Treat Rep; 1986 Feb; 70(2):271-4. PubMed ID: 3948191
[TBL] [Abstract][Full Text] [Related]
4. High-dose doxorubicin infusion therapy for disseminated mixed mesodermal sarcoma of the uterus.
Gershenson DM; Kavanagh JJ; Copeland LJ; Edwards CL; Freedman RS; Wharton JT
Cancer; 1987 Apr; 59(7):1264-7. PubMed ID: 3815302
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide, hexamethylmelamine, adriamycin and cisplatin combination chemotherapy in mixed mesodermal sarcoma of the female genital tract.
Jansen RL; van der Burg ME; Verweij J; Stoter G
Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1131-3. PubMed ID: 3115787
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study.
Thigpen JT; Blessing JA; Beecham J; Homesley H; Yordan E
J Clin Oncol; 1991 Nov; 9(11):1962-6. PubMed ID: 1941054
[TBL] [Abstract][Full Text] [Related]
7. Prospective trial of cisplatin, adriamycin, and dacarbazine in metastatic mixed mesodermal sarcomas of the uterus and ovary.
Baker TR; Piver MS; Caglar H; Piedmonte M
Am J Clin Oncol; 1991 Jun; 14(3):246-50. PubMed ID: 2031513
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin and cisplatin in the treatment of advanced mixed mesodermal uterine sarcoma.
Seltzer V; Kaplan B; Vogl S; Spitzer M
Cancer Treat Rep; 1984 Nov; 68(11):1389-90. PubMed ID: 6541972
[No Abstract] [Full Text] [Related]
9. [A clinical analysis of 153 uterine sarcomas].
Bai P; Sun J; Chao H
Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):163-7. PubMed ID: 9596892
[TBL] [Abstract][Full Text] [Related]
10. Phase I/II trial of external irradiation plus medium-dose brachytherapy given concurrently to liposomal doxorubicin and cisplatin for advanced uterine cervix carcinoma.
Varveris H; Kachris S; Mazonakis M; Lyraraki E; Petineli E; Varveris A; Fasoulaki A; Tzedakis A; Kouloulias V; Zolindaki A; Vlachaki M
Strahlenther Onkol; 2006 Mar; 182(3):125-34. PubMed ID: 16520906
[TBL] [Abstract][Full Text] [Related]
11. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study.
Sutton G; Brunetto VL; Kilgore L; Soper JT; McGehee R; Olt G; Lentz SS; Sorosky J; Hsiu JG
Gynecol Oncol; 2000 Nov; 79(2):147-53. PubMed ID: 11063636
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study.
Omura GA; Blessing JA; Major F; Lifshitz S; Ehrlich CE; Mangan C; Beecham J; Park R; Silverberg S
J Clin Oncol; 1985 Sep; 3(9):1240-5. PubMed ID: 3897471
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study.
Sutton G; Kauderer J; Carson LF; Lentz SS; Whitney CW; Gallion H;
Gynecol Oncol; 2005 Mar; 96(3):630-4. PubMed ID: 15721404
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of etoposide, cisplatin, and doxorubicin chemotherapy in mixed müllerian tumors (MMT) of the uterus.
Resnik E; Chambers SK; Carcangiu ML; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1995 Mar; 56(3):370-5. PubMed ID: 7705670
[TBL] [Abstract][Full Text] [Related]
15. High-dose cisplatin for metastatic soft tissue sarcoma.
Budd GT; Metch B; Balcerzak SP; Fletcher WS; Baker LH; Mortimer JE
Cancer; 1990 Feb; 65(4):866-9. PubMed ID: 2297655
[TBL] [Abstract][Full Text] [Related]
16. Systemic therapy for advanced uterine sarcoma: a systematic review of the literature.
Kanjeekal S; Chambers A; Fung MF; Verma S
Gynecol Oncol; 2005 May; 97(2):624-37. PubMed ID: 15863170
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin chemotherapy for disseminated endometrial cancer.
Seski JC; Edwards CL; Herson J; Rutledge FN
Obstet Gynecol; 1982 Feb; 59(2):225-8. PubMed ID: 7043339
[TBL] [Abstract][Full Text] [Related]
18. [Combination chemotherapy of uterine sarcomas].
Bai P; Zhang W; Sun J
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):80-2. PubMed ID: 11776610
[TBL] [Abstract][Full Text] [Related]
19. Mitoxantrone in the treatment of advanced uterine sarcoma. A phase II trial of the Gynecologic Oncology Group.
Muss HB; Bundy BN; Adcock L; Beecham J
Am J Clin Oncol; 1990 Feb; 13(1):32-4. PubMed ID: 2154921
[TBL] [Abstract][Full Text] [Related]
20. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
